Guardant Health

Company Overview

Guardant Health is a precision oncology firm that provides specialized testing by leveraging its vast data sets and cutting-edge analytics to help fight cancer all around the world. It offers Guardant360 LDT, Guardant360 CDx, Guardant360 TissueNext, Guardant360 Response and GuardantOMNI tests for advanced-stage cancer patients and Guardant Reveal for early-stage cancer patients. The Guardant Health screening portfolio, including the Shield test, aims to address the needs of individuals eligible for cancer screening. The company manages its business in two reportable segments: precision oncology testing and development services and others.

The company performs its tests in its laboratories in Redwood City, Calif. and San Diego, Calif. Its Redwood City laboratory is CAP accredited, CLIA-certified, NYSDOH-permitted and licensed in California, Florida, Maryland, Pennsylvania and Rhode Island and achieved ISO15189 accreditation. Its San Diego laboratory is CAP-accredited and CLIA-certified. The company has also received CAP accreditation and IVD sample processing approval from the MHLW for its laboratory in Japan.

Financial Highlights (FY 2024)

Company's Business Segments

• Precision Oncology Testing : Precision oncology testing revenue is generated from sales of tests to clinical and biopharmaceutical customers, which comprises tests provided by labs operated by the company's strategic partners.
• Development Services : This segment primarily provides services to biopharmaceutical companies, large medical institutions, and international laboratory partners.